Miyauchi S - Search Results

1

STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling.

Arimoto KI, Löchte S, Stoner SA, Burkart C, Zhang Y, Miyauchi S, Wilmes S, Fan JB, Heinisch JJ, Li Z, Yan M, Pellegrini S, Colland F, Piehler J, Zhang DE. Arimoto KI, et al. Among authors: miyauchi s. Nat Struct Mol Biol. 2017 Mar;24(3):279-289. doi: 10.1038/nsmb.3378. Epub 2017 Feb 6. Nat Struct Mol Biol. 2017. PMID: 28165510 Free PMC article.

2

Negative regulation of type I IFN signaling.

Arimoto KI, Miyauchi S, Stoner SA, Fan JB, Zhang DE. Arimoto KI, et al. Among authors: miyauchi s. J Leukoc Biol. 2018 Jan 22. doi: 10.1002/JLB.2MIR0817-342R. Online ahead of print. J Leukoc Biol. 2018. PMID: 29357192 Review.

3

Type I Interferon Regulates a Coordinated Gene Network to Enhance Cytotoxic T Cell-Mediated Tumor Killing.

Fan JB, Miyauchi S, Xu HZ, Liu D, Kim LJY, Burkart C, Cheng H, Arimoto KI, Yan M, Zhou Y, Győrffy B, Knobeloch KP, Rich JN, Cang H, Fu XD, Zhang DE. Fan JB, et al. Among authors: miyauchi s. Cancer Discov. 2020 Mar;10(3):382-393. doi: 10.1158/2159-8290.CD-19-0608. Epub 2020 Jan 23. Cancer Discov. 2020. PMID: 31974171 Free PMC article.

4

RUNX1 deficiency cooperates with SRSF2 mutation to induce multilineage hematopoietic defects characteristic of MDS.

Huang YJ, Chen JY, Yan M, Davis AG, Miyauchi S, Chen L, Hao Y, Katz S, Bejar R, Abdel-Wahab O, Fu XD, Zhang DE. Huang YJ, et al. Among authors: miyauchi s. Blood Adv. 2022 Dec 13;6(23):6078-6092. doi: 10.1182/bloodadvances.2022007804. Blood Adv. 2022. PMID: 36206200 Free PMC article.

5

B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade.

Kim SS, Shen S, Miyauchi S, Sanders PD, Franiak-Pietryga I, Mell L, Gutkind JS, Cohen EEW, Califano JA, Sharabi AB. Kim SS, et al. Among authors: miyauchi s. Clin Cancer Res. 2020 Jul 1;26(13):3345-3359. doi: 10.1158/1078-0432.CCR-19-3211. Epub 2020 Mar 19. Clin Cancer Res. 2020. PMID: 32193227 Free PMC article.

6

[No title available]

[No authors listed] [No authors listed] PMID: 34700444

7

Immune Modulation of Head and Neck Squamous Cell Carcinoma and the Tumor Microenvironment by Conventional Therapeutics.

Miyauchi S, Kim SS, Pang J, Gold KA, Gutkind JS, Califano JA, Mell LK, Cohen EEW, Sharabi AB. Miyauchi S, et al. Clin Cancer Res. 2019 Jul 15;25(14):4211-4223. doi: 10.1158/1078-0432.CCR-18-0871. Epub 2019 Feb 27. Clin Cancer Res. 2019. PMID: 30814108 Free PMC article. Review.

8

Role of B Cells in Responses to Checkpoint Blockade Immunotherapy and Overall Survival of Cancer Patients.

Kim SS, Sumner WA, Miyauchi S, Cohen EEW, Califano JA, Sharabi AB. Kim SS, et al. Among authors: miyauchi s. Clin Cancer Res. 2021 Nov 15;27(22):6075-6082. doi: 10.1158/1078-0432.CCR-21-0697. Epub 2021 Jul 6. Clin Cancer Res. 2021. PMID: 34230025 Free PMC article. Review.

9

HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer.

Miyauchi S, Sanders PD, Guram K, Kim SS, Paolini F, Venuti A, Cohen EEW, Gutkind JS, Califano JA, Sharabi AB. Miyauchi S, et al. Cancer Res. 2020 Feb 15;80(4):732-746. doi: 10.1158/0008-5472.CAN-19-1771. Epub 2019 Dec 17. Cancer Res. 2020. PMID: 31848196 Free PMC article.

10

Activated B Cells and Plasma Cells Are Resistant to Radiation Therapy.

Franiak-Pietryga I, Miyauchi S, Kim SS, Sanders PD, Sumner W, Zhang L, Mundt AJ, Califano JA, Sharabi AB. Franiak-Pietryga I, et al. Among authors: miyauchi s. Int J Radiat Oncol Biol Phys. 2022 Feb 1;112(2):514-528. doi: 10.1016/j.ijrobp.2021.08.037. Epub 2021 Aug 30. Int J Radiat Oncol Biol Phys. 2022. PMID: 34474108 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

534 results

Search Page